Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Location

Market Cap

USD 7.56 B

Share Price

USD 15.29

Avg Daily Volume

3,111,760

Change (1 day)

11.61%

Change (1 year)

377.81%

Change (YTD)

209.51%

Regencell Bioscience Holdings Limited EBIT Margin for the Trailing 12 Months (TTM) ending July 18, 2025: N/A

Regencell Bioscience Holdings Limited EBIT Margin is NA for the Trailing 12 Months (TTM) ending July 18, 2025. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin